Related Experiment Video
Updated: Oct 19, 2026

Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
Recent advances in medical hemostatic materials: Mechanisms, evaluation, and clinical perspectives
Weifan Xu1, Xing Pang1, Yingli Zhu2
1School of Medical Imaging, Wannan Medical University, Wuhu 241002, China.
Abstract:
Uncontrolled hemorrhage remains a major cause of preventable death in trauma and surgery, yet the performance of hemostatic materials varies markedly with wound geometry, blood flow, coagulation status, and tissue sensitivity. This review critically examines natural polymer-based, synthetic polymer-based, inorganic, and composite hemostats by linking material structure to six principal mechanisms: fluid absorption and surface adsorption, coagulation activation, bioactive-factor delivery, photothermal assistance, adhesive sealing, and microstructural regulation. Beyond cataloging materials, we compare class-specific advantages, failure modes, and safety constraints, and analyze how hemodilution, hypothermia, acidosis, anticoagulation, infection, and high-flow bleeding reshape material performance. We further integrate clinically used products, scenario-based material selection, and a staged evaluation framework spanning mechanistic assays, hostile-condition testing, translational bleeding models, rebleeding assessment, and post-hemostasis safety. Finally, we outline stage-matched pathways for responsive and multifunctional systems. This mechanism-scenario-evaluation framework supports more rigorous design, comparison, and clinical translation of next-generation hemostatic materials.
Related Concept Videos
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized, and...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis III: Interprofessional Care
